All In Biotech

Drug Trial Radar · NCT06717425

A Study to Learn About the Study Medicine Called PF-07976016 in Adults With Obesity

A PHASE 2A, RANDOMIZED, DOUBLE-BLIND, SPONSOR-OPEN, PLACEBO-CONTROLLED, PARALLEL GROUP, DOSE-RANGING STUDY OF PF-07976016 TO ASSESS SAFETY AND EFFICACY IN ADULT PARTICIPANTS WITH OBESITY

Last checked: Nov 19, 2026Latest source record: Feb 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 263 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

263

Actual

Start

Dec 9, 2024

Primary completion

Oct 23, 2025

Study completion Jan 12, 2026

Sponsor

Lead sponsor
PfizerPfizer (PFE)
Sponsor type
Industry
First posted
Dec 5, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 74 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this clinical trial is to learn about the safety and effects of the study medicine (called PF-07976016) for the potential treatment of obesity. The study will compare the experiences of participants taking the study medicine (PF-07976016) to those of participants who take placebo (a lookalike substance that contains no active study medicine). The aim is to measure the body's response to the study medicine, including any changes in participants' body weight and how well they tolerate the study medicine.

Conditions

  • Obesity

Interventions

  • PF-07976016Drug

    Taken once daily

  • PlaceboDrug

    Taken once daily

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percent change from baseline in body weightTime frame: Baseline to Week 16

Locations

38 sites in 3 countries. Site status is shown where the registry gives one.

  • Anaheim Clinical Trials, LLC

    Anaheim, California

  • Artemis Institute for Clinical Research

    San Diego, California

  • Clinical & Translational Research Center

    Aurora, Colorado

  • University of Colorado Anschutz Medical Campus

    Aurora, Colorado

  • Westside Center for Clinical Research

    Jacksonville, Florida

  • New Horizon Research Center

    Miami, Florida

  • Renstar Medical Research

    Ocala, Florida

  • Renstar Medical Research

    Ocala, Florida

  • St Johns Center for Clinical Research

    Saint Augustine, Florida

  • Rophe Adult and Pediatric Medicine/SKYCRNG

    Union City, Georgia

  • East-West Medical Research Institute

    Honolulu, Hawaii

  • Cotton O'Neil Diabetes & Endocrinology

    Topeka, Kansas

  • L-MARC Research Center

    Louisville, Kentucky

  • Pennington Biomedical Research Center

    Baton Rouge, Louisiana

  • StudyMetrix Research

    City of Saint Peters, Missouri

  • Rochester Clinical Research, LLC

    Rochester, New York

  • Accellacare - Wilmington

    Wilmington, North Carolina

  • AMR Clinical

    Norman, Oklahoma

  • Cornerstone Nutrition and Diabetes

    Norman, Oklahoma

  • Capital Area Research, LLC

    Camp Hill, Pennsylvania

  • Elligo Clinical Research Center

    Austin, Texas

  • Texas Diabetes & Endocrinology, P.A.

    Austin, Texas

  • Velocity Clinical Research, Dallas

    Dallas, Texas

  • UT Southwestern Medical Center

    Dallas, Texas

  • Consano Clinical Research, LLC

    Shavano Park, Texas

  • Chrysalis Clinical Research

    St. George, Utah

  • Southwest Internal Medicine, PC

    St. George, Utah

  • Selma Medical Associates

    Winchester, Virginia

  • Ocean West Research Clinic

    Surrey, British Columbia, Canada

  • Dawson Clinical Research Inc.

    Guelph, Ontario, Canada

  • The Wharton Medical Clinic Clinical Trials Inc.

    Hamilton, Ontario, Canada

  • Milestone Research Inc.

    London, Ontario, Canada

  • Canadian Phase Onward

    Toronto, Ontario, Canada

  • Centrum Zdrowia Metabolicznego Pawel Bogdanski

    Poznan, Greater Poland Voivodeship, Poland

  • Medicome Sp. z o. o.

    Oświęcim, Lesser Poland Voivodeship, Poland

  • Ekamed

    Lublin, Lublin Voivodeship, Poland

  • Centrum Badan Klinicznych PI-House sp. z o.o.

    Gdansk, Pomeranian Voivodeship, Poland

  • Centrum Medyczne Pratia Gdynia

    Gdynia, Pomeranian Voivodeship, Poland

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.